Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wen, Fuqiang F
NCT06643078: A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients with COPD	Recruiting	3	474	RoW	HL231 Solution for Inhalation, Ultibro 110μg/50 μg	Haisco Pharmaceutical Group Co., Ltd., Sichuan Haisco Pharmaceutical Group Co., Ltd	Chronic Obstructive Pulmonary Disease (COPD)	10/25	10/25